Skip to main content
TipRanks
Go Ultimate75% OFF

Immunocore Holdings (IMCR) Stock Statistics & Valuation Metrics

258 Followers

Total Valuation

Immunocore Holdings has a market cap or net worth of $1.55B. The enterprise value is $1.10B.

Market Cap
$1.55B
Enterprise Value
$1.10B

Share Statistics

Immunocore Holdings has 51,681,377 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
51,681,377
Owned by Insiders
0.04%
Owned by Institutions
36.11%

Financial Efficiency

Immunocore Holdings’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -5.51%.

Return on Equity (ROE)
-0.09
Return on Assets (ROA)
-0.03
Return on Invested Capital (ROIC)
-5.51%
Return on Capital Employed (ROCE)
-0.06
Revenue Per Employee
763.39K
Profits Per Employee
-67.77K
Employee Count
524
Asset Turnover
0.37
Inventory Turnover
1.24

Valuation Ratios

The current PE Ratio of Immunocore Holdings is -47.31. Immunocore Holdings’s PEG ratio is 0.58.

PE Ratio
-47.31
PS Ratio
3.60
PB Ratio
3.68
Price to FCF
-39.05
Price to Operating Cash Flow
-48.56
PEG Ratio
0.58

Income Statement

In the last 12 months, Immunocore Holdings had revenue of 400.02M and earned -35.51M in profits. Earnings per share was -0.71.

Revenue
400.02M
Gross Profit
391.66M
Operating Income
-45.35M
Pretax Income
-19.10M
Net Income
-35.51M
EBITDA
520.00K
Earnings Per Share (EPS)
-0.71

Cash Flow

In the last 12 months, operating cash flow was -31.79M and capital expenditures -7.79M, giving a free cash flow of -39.59M billion.

Operating Cash Flow
-31.79M
Free Cash Flow
-39.59M
Free Cash Flow per Share
-0.77

Dividends & Yields

Immunocore Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-2.56%
Earnings Yield
-2.08%

Stock Price Statistics

Beta
0.45
52-Week Price Change
-15.35%
50-Day Moving Average
31.07
200-Day Moving Average
31.59
Relative Strength Index (RSI)
45.69
Average Volume (3m)
461.24K

Important Dates

Immunocore Holdings upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 11, 2026
Next Earnings Date
Mar 03, 2027
Ex-Dividend Date
―

Financial Position

Immunocore Holdings as a current ratio of 4.04, with Debt / Equity ratio of 114.61%

Current Ratio
4.04
Quick Ratio
4.01
Debt to Market Cap
0.22
Net Debt to EBITDA
-59.66
Interest Coverage Ratio
-2.77

Taxes

In the past 12 months, Immunocore Holdings has paid 16.41M in taxes.

Income Tax
16.41M
Effective Tax Rate
-0.86

Enterprise Valuation

Immunocore Holdings EV to EBITDA ratio is -859.99, with an EV/FCF ratio of -37.12.

EV to Sales
3.42
EV to EBITDA
-859.99
EV to Free Cash Flow
-37.12
EV to Operating Cash Flow
-46.22

Balance Sheet

Immunocore Holdings has $901.30M in cash and marketable securities with $435.74M in debt, giving a net cash position of $465.56M billion.

Cash & Marketable Securities
$901.30M
Total Debt
$435.74M
Net Cash
$465.56M
Net Cash Per Share
$9.01
Tangible Book Value Per Share
$8.14

Margins

Gross margin is 98.86%, with operating margin of -6.76%, and net profit margin of -7.48%.

Gross Margin
98.86%
Operating Margin
-6.76%
Pretax Margin
-3.98%
Net Profit Margin
-7.48%
EBITDA Margin
-0.40%
EBIT Margin
-1.31%

Analyst Forecast

The average price target for Immunocore Holdings is $56.80, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
$56.80
Price Target Upside
89.71% Upside
Analyst Consensus
Moderate Buy
Analyst Count
5
Revenue Growth Forecast
13.01%
EPS Growth Forecast
―

Scores

Smart Score
4
AI Score
52